Literature DB >> 10545989

Transplantation tolerance-where do we stand?

H Waldmann1.   

Abstract

Our understanding of tolerance mechanisms has progressed to the point that tolerance-induction protocols are being tested in humans for organ transplantation. However, a range of scientific, ethical, logistic and commercial issues have arisen, and must be resolved before tolerance induction for human allograft patients can become a reality.

Entities:  

Mesh：

Year:  1999        PMID： 10545989     DOI： 10.1038/15197

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  12 in total

Review 1.  Transplantation tolerance from a historical perspective.

Authors:  T E Starzl; R M Zinkernagel
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

Review 2.  Challenges to achieving clinical transplantation tolerance.

Authors:  A D Salama; G Remuzzi; W E Harmon; M H Sayegh
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 3.  An update on regulatory T cells in transplant tolerance and rejection.

Authors:  Xian Chang Li; Laurence A Turka
Journal:  Nat Rev Nephrol       Date:  2010-08-03       Impact factor: 28.314

Review 4.  Enhancing clinical islet transplantation through tissue engineering strategies.

Authors:  Jaime A Giraldo; Jessica D Weaver; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 5.  The unfinished legacy of liver transplantation: emphasis on immunology.

Authors:  Thomas E Starzl; Fadi G Lakkis
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 6.  Autoimmune mechanisms as the basis for human peripartum cardiomyopathy.

Authors:  Aftab A Ansari; James D Fett; Robert E Carraway; Ann E Mayne; Nattawat Onlamoon; J Bruce Sundstrom
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

Review 7.  CD4+CD25+ regulatory T lymphocytes in bone marrow transplantation.

Authors:  Olivier Joffre; Joost P M van Meerwijk
Journal:  Semin Immunol       Date:  2006-02-03       Impact factor: 11.130

8.  Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells.

Authors:  F M Abomaray; M A Al Jumah; B Kalionis; A S AlAskar; S Al Harthy; D Jawdat; A Al Khaldi; A Alkushi; B A Knawy; M H Abumaree
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

9.  Vascularized composite allograft rejection is delayed by intrajejunal treatment with donor splenocytes without concomitant immunosuppressants.

Authors:  Christopher Glenn Wallace; Chia-Hung Yen; Hsiang-Chen Yang; Chun-Yen Lin; Ren-Chin Wu; Wei-Chao Huang; Jeng-Yee Lin; Fu-Chan Wei
Journal:  Clin Dev Immunol       Date:  2012-11-27

10.  STAT-1 decoy oligodeoxynucleotide inhibition of acute rejection in mouse heart transplants.

Authors:  Tomislav Stojanovic; Andreas H Wagner; Shijun Wang; Eva Kiss; Nicolas Rockstroh; Jens Bedke; Hermann-Josef Gröne; Markus Hecker
Journal:  Basic Res Cardiol       Date:  2009-04-08       Impact factor: 17.165
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.